GlaxoSmithKline (GSK), the world’s fourth largest drug maker, has entered into an equal joint venture agreement with Biological-E Ltd., a vaccines company based in Hyderabad, recently. The report has unveiled that the two companies are giving a shot to a six-in-one vaccine.
The companies would conduct a deep research as they are aiming at developing such a combination paediatric vaccine that protects children in developing nations like India. It is being hoped that the combination vaccine could fight not only polio, but other infectious diseases as well.
{iframe}http://www.frenchtribune.com/teneur/1315706-gsk-signs-agreement-biological-e-six-one-polio-vaccine{/iframe}